12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

AmpliPhi BioSciences, Celladon preclinical data

In rat models of PAH, Mydicar administered through a nebulizer-like inhalation device completely reversed the disease. Data were published in Circulation. A single intracoronary infusion...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >